A C-peptide test is a blood test that measures the levels of C-peptide, a protein produced by the pancreas. It is used to diagnose and monitor type 1 diabetes, a condition where the body's immune system attacks and destroys the cells in the pancreas that produce insulin. C-peptide levels are typically low or undetectable in people with type 1 diabetes, as the pancreas is unable to produce insulin. The test is also used to monitor the effectiveness of insulin therapy and to detect potential complications, such as hypoglycemia or hyperglycemia. In addition, C-peptide testing can be used to distinguish between type 1 and type 2 diabetes, as people with type 2 diabetes often have higher C-peptide levels due to the presence of insulin resistance.
A C-peptide blood test measures the level of C-peptide in the blood, which is produced when insulin is made in the pancreas. The test helps evaluate insulin production, distinguish between types of diabetes, monitor insulin therapy, and detect insulinoma. The test requires a blood sample and results can be influenced by factors like diet and medication. It's important to follow healthcare provider instructions before taking the test.
108 4.74
A diabetes panel consists of blood tests used to diagnose and manage diabetes by measuring blood sugar levels and assessing insulin production and utilization. Tests may include fasting blood sugar, hemoglobin A1c, oral glucose tolerance, insulin level, and C-peptide tests. The results help healthcare providers diagnose diabetes, determine its type, monitor blood sugar control, and adjust treatment plans. Regular monitoring with a diabetes panel is essential for individuals at risk for or with diabetes to effectively manage the condition.